Pionyr Immunotherapeutics

Business Data, Corporate Office and Headquarter Address

About

Pionyr Immunotherapeutics is Drug Discovery in United States that focus on developer business. Founded in 2015. They cover business area such as developer, cancer immunotherapy, high specificity, patient, combination, checkpoint inhibitor.

Business Type

Drug Discovery

Country

United States

Founded

2015
( 9 years old in 2024 )

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

2 Tower Place
Suite 800
South San Francisco, CA 94080
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developercancer immunotherapyhigh specificitypatientcombinationcheckpoint inhibitor

* We use standard office opening hours in near Pionyr Immunotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Pionyr Immunotherapeutics Frequently Asked Questions

What or who is Pionyr Immunotherapeutics?

Pionyr Immunotherapeutics is Drug Discovery business from United States that founded in 2015 (9 years old in 2024), Pionyr Immunotherapeutics business is focusing on Developer.

Where is Pionyr Immunotherapeutics headquarter and corporate office address?

Pionyr Immunotherapeutics headquarter office and corporate office address is located in 2 Tower Place Suite 800 South San Francisco, CA 94080 United States.

Where is Pionyr Immunotherapeutics country origins?

Pionyr Immunotherapeutics was founded in United States.

What is Developer business focus on?

In 2024, Pionyr Immunotherapeutics is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Pionyr Immunotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.